rs55824172
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_013254.4(TBK1):c.452C>G(p.Ser151Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000192 in 1,612,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_013254.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBK1 | NM_013254.4 | c.452C>G | p.Ser151Cys | missense_variant | Exon 5 of 21 | ENST00000331710.10 | NP_037386.1 | |
TBK1 | XM_005268809.2 | c.452C>G | p.Ser151Cys | missense_variant | Exon 5 of 21 | XP_005268866.1 | ||
TBK1 | XM_005268810.2 | c.452C>G | p.Ser151Cys | missense_variant | Exon 5 of 21 | XP_005268867.1 | ||
TBK1 | XR_007063071.1 | n.551C>G | non_coding_transcript_exon_variant | Exon 5 of 18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250376Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135400
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460424Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726552
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
TBK1-related disorder Uncertain:1
The TBK1 c.452C>G variant is predicted to result in the amino acid substitution p.Ser151Cys. To our knowledge, this variant has not been reported in individuals with TBK1-related disorders. The p.Ser151Cys substitution has been reported to decrease TBK1 kinase activity (Ye et al. 2019. PubMed ID: 31748271). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-64860774-C-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Uncertain:1
This sequence change replaces serine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 151 of the TBK1 protein (p.Ser151Cys). This variant is present in population databases (no rsID available, gnomAD 0.002%). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (Invitae). ClinVar contains an entry for this variant (Variation ID: 1464768). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBK1 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects TBK1 function (PMID: 31748271). This variant disrupts the p.Ser151 amino acid residue in TBK1. Other variant(s) that disrupt this residue have been observed in individuals with TBK1-related conditions (Invitae), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at